Regulating human implant technologies in Europe - Understanding the new era in medical device regulation

Health, Risk and Society

Volumn 4, Issue 2, 2002, Pages 189-209

  Kent, Julie ^a   Faulkner, Alex ^a  

^a UNIVERSITY OF THE WEST OF ENGLAND   (United Kingdom)

Author keywords

Breast implants; Hip prostheses; Medical devices; Regulation; Risk

Indexed keywords

ARTICLE; BREAST ENDOPROSTHESIS; CONTROLLED STUDY; EUROPEAN UNION; HEALTH HAZARD; HIP PROSTHESIS; HUMAN; IMPLANT; MEDICAL TECHNOLOGY; NATIONAL HEALTH SERVICE; PROSTHESIS; PUBLIC HEALTH; RISK BENEFIT ANALYSIS; SAFETY; UNITED KINGDOM;

EID: 0036088727     PISSN: 13698575     EISSN: None     Source Type: Journal    
DOI: 10.1080/13698570220137060     Document Type: Article

References (89)

1. The science and politics of medicines regulation
2. International comparative analysis and explanation in medical sociology: Demystifying the Halcion anomaly
3. Technical position statement on the safety of Trilucent Breast Implant
4. Regulating healthcare technologies and medical supplies in the European Economic Area
5. Patient satisfaction with Trilucent breast implants
6. Adverse incident reporting to the Medical Devices Agency-a review of reports involving Trilucent breast implants
7. Bleed of and biologic response to triglyceride filler used in radiolucent breast implants
8. Risk society revisited: Theory, politics and research programmes
9. What is policy convergence and what causes it?
10. EC safety moves over silicone breast implants
11. Regulatory science and the social management of trust in medicine
12. Spanish women sue over breast implants
13. 'Safe' breast implant is banned
14. Bleed of and biologic response to triglyceride filler used in radiolucent breast implants
15. Local tissue reaction to oil-based breast implant bleed
16. Characteristics of women with and without breast augmentation
17. Breast implants information for women considering breast implants
18. The construction of lay expertise: AIDS activism and the forging of credibility in the reform of clinical trials
19. Casing the joint: The material development of artificial hips
20. Effectiveness of hip prostheses in primary total hip replacement: A critical review of evidence and an economic model
21. Innovation and regulation of human implant technologies: Developing comparative approaches
22. Medical device governance: Regulation of tissue engineering in the UK and EU
23. Primary total hip replacement surgery: A systematic review of outcomes and modelling of cost-effectiveness associated with different prostheses
24. Programming nature and public participation in decision-making: A European perspective
25. Risks, the public and the Human Genome Project
26. Silicone gel breast implants. The report of the independent review group
27. Constructing the scientific citizen: Science and democracy in the biosciences
28. Regulatory science-towards a sociological framework
29. Engineering body parts: A sociological approach to developments in tissue engineering
30. Post-marketing surveillance of human implant technologies in the European Union
31. The new genetics and health: Mobilising lay expertise
32. Scientific knowledge controversy and public decision making
33. Health Risks Posed by Silicone Implants in General, with Special Attention to Breast Implants
34. Early femoral loosening in one design of cemented hip replacement
35. Breast implants
36. Experience with soybean oil-filled breast implants in Swedish surgical practice
37. Early aseptic loosening in one design (3M-Capital) of cemented total hip replacement
38. Social justice, federal paternalism and feminism: Breast implants in the cultural context of female beauty
39. Development of standards for orthopaedic implants
40. Global harmonization task force roles and responsibilities
41. 1H) NMR Analysis of Lipid Peroxidation Products in Soybean Oil Samples from Explanted and Retained Breast Implants
42. Breast implants: A gender issue
43. Trilucent breast implants: A 3 year series
44. An Investigation of the Performance of the 3M™ Capital™ Hip System
45. Risk society or angst society?
46. It goes against the grain-public understandings of genetically-modified (GM) food
47. Statement of Swiss Health Office-Trilucent breast implants
48. European developments relating to breast implants
49. Assessment of cancer risk associated with exposure to soybean oil filler compounds and peroxidation products potentially released from Trilucent breast implants
50. Bleed of and biologic response to Triglyceride filler used in radiolucent breast implants
51. Public representations of scientific uncertainty about global climate change